Entry |
|
Symbol |
KRAS
|
Name |
(RefSeq) GTPase KRas isoform X1
|
KO |
|
Organism |
pon Pongo abelii (Sumatran orangutan)
|
Pathway |
pon01521 | EGFR tyrosine kinase inhibitor resistance |
pon04072 | Phospholipase D signaling pathway |
pon04213 | Longevity regulating pathway - multiple species |
pon04550 | Signaling pathways regulating pluripotency of stem cells |
pon04625 | C-type lectin receptor signaling pathway |
pon04650 | Natural killer cell mediated cytotoxicity |
pon04660 | T cell receptor signaling pathway |
pon04662 | B cell receptor signaling pathway |
pon04664 | Fc epsilon RI signaling pathway |
pon04810 | Regulation of actin cytoskeleton |
pon04914 | Progesterone-mediated oocyte maturation |
pon04919 | Thyroid hormone signaling pathway |
pon04933 | AGE-RAGE signaling pathway in diabetic complications |
pon04935 | Growth hormone synthesis, secretion and action |
pon04960 | Aldosterone-regulated sodium reabsorption |
pon05022 | Pathways of neurodegeneration - multiple diseases |
pon05163 | Human cytomegalovirus infection |
pon05166 | Human T-cell leukemia virus 1 infection |
pon05167 | Kaposi sarcoma-associated herpesvirus infection |
pon05170 | Human immunodeficiency virus 1 infection |
pon05207 | Chemical carcinogenesis - receptor activation |
pon05208 | Chemical carcinogenesis - reactive oxygen species |
pon05230 | Central carbon metabolism in cancer |
pon05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Brite |
KEGG Orthology (KO) [BR:pon00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100462513 (KRAS)
04012 ErbB signaling pathway
100462513 (KRAS)
04014 Ras signaling pathway
100462513 (KRAS)
04015 Rap1 signaling pathway
100462513 (KRAS)
04370 VEGF signaling pathway
100462513 (KRAS)
04371 Apelin signaling pathway
100462513 (KRAS)
04068 FoxO signaling pathway
100462513 (KRAS)
04072 Phospholipase D signaling pathway
100462513 (KRAS)
04071 Sphingolipid signaling pathway
100462513 (KRAS)
04151 PI3K-Akt signaling pathway
100462513 (KRAS)
04150 mTOR signaling pathway
100462513 (KRAS)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
100462513 (KRAS)
04137 Mitophagy - animal
100462513 (KRAS)
09143 Cell growth and death
04210 Apoptosis
100462513 (KRAS)
04218 Cellular senescence
100462513 (KRAS)
09144 Cellular community - eukaryotes
04540 Gap junction
100462513 (KRAS)
04550 Signaling pathways regulating pluripotency of stem cells
100462513 (KRAS)
09142 Cell motility
04810 Regulation of actin cytoskeleton
100462513 (KRAS)
09150 Organismal Systems
09151 Immune system
04625 C-type lectin receptor signaling pathway
100462513 (KRAS)
04650 Natural killer cell mediated cytotoxicity
100462513 (KRAS)
04660 T cell receptor signaling pathway
100462513 (KRAS)
04662 B cell receptor signaling pathway
100462513 (KRAS)
04664 Fc epsilon RI signaling pathway
100462513 (KRAS)
04062 Chemokine signaling pathway
100462513 (KRAS)
09152 Endocrine system
04910 Insulin signaling pathway
100462513 (KRAS)
04929 GnRH secretion
100462513 (KRAS)
04912 GnRH signaling pathway
100462513 (KRAS)
04915 Estrogen signaling pathway
100462513 (KRAS)
04914 Progesterone-mediated oocyte maturation
100462513 (KRAS)
04917 Prolactin signaling pathway
100462513 (KRAS)
04921 Oxytocin signaling pathway
100462513 (KRAS)
04926 Relaxin signaling pathway
100462513 (KRAS)
04935 Growth hormone synthesis, secretion and action
100462513 (KRAS)
04919 Thyroid hormone signaling pathway
100462513 (KRAS)
04916 Melanogenesis
100462513 (KRAS)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
100462513 (KRAS)
09156 Nervous system
04725 Cholinergic synapse
100462513 (KRAS)
04726 Serotonergic synapse
100462513 (KRAS)
04720 Long-term potentiation
100462513 (KRAS)
04730 Long-term depression
100462513 (KRAS)
04722 Neurotrophin signaling pathway
100462513 (KRAS)
09158 Development and regeneration
04360 Axon guidance
100462513 (KRAS)
09149 Aging
04211 Longevity regulating pathway
100462513 (KRAS)
04213 Longevity regulating pathway - multiple species
100462513 (KRAS)
09159 Environmental adaptation
04714 Thermogenesis
100462513 (KRAS)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100462513 (KRAS)
05206 MicroRNAs in cancer
100462513 (KRAS)
05205 Proteoglycans in cancer
100462513 (KRAS)
05207 Chemical carcinogenesis - receptor activation
100462513 (KRAS)
05208 Chemical carcinogenesis - reactive oxygen species
100462513 (KRAS)
05203 Viral carcinogenesis
100462513 (KRAS)
05230 Central carbon metabolism in cancer
100462513 (KRAS)
05231 Choline metabolism in cancer
100462513 (KRAS)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100462513 (KRAS)
09162 Cancer: specific types
05210 Colorectal cancer
100462513 (KRAS)
05212 Pancreatic cancer
100462513 (KRAS)
05225 Hepatocellular carcinoma
100462513 (KRAS)
05226 Gastric cancer
100462513 (KRAS)
05214 Glioma
100462513 (KRAS)
05216 Thyroid cancer
100462513 (KRAS)
05221 Acute myeloid leukemia
100462513 (KRAS)
05220 Chronic myeloid leukemia
100462513 (KRAS)
05218 Melanoma
100462513 (KRAS)
05211 Renal cell carcinoma
100462513 (KRAS)
05219 Bladder cancer
100462513 (KRAS)
05215 Prostate cancer
100462513 (KRAS)
05213 Endometrial cancer
100462513 (KRAS)
05224 Breast cancer
100462513 (KRAS)
05223 Non-small cell lung cancer
100462513 (KRAS)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100462513 (KRAS)
05170 Human immunodeficiency virus 1 infection
100462513 (KRAS)
05161 Hepatitis B
100462513 (KRAS)
05160 Hepatitis C
100462513 (KRAS)
05163 Human cytomegalovirus infection
100462513 (KRAS)
05167 Kaposi sarcoma-associated herpesvirus infection
100462513 (KRAS)
05165 Human papillomavirus infection
100462513 (KRAS)
09164 Neurodegenerative disease
05010 Alzheimer disease
100462513 (KRAS)
05022 Pathways of neurodegeneration - multiple diseases
100462513 (KRAS)
09165 Substance dependence
05034 Alcoholism
100462513 (KRAS)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100462513 (KRAS)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
100462513 (KRAS)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100462513 (KRAS)
01522 Endocrine resistance
100462513 (KRAS)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:pon04131]
100462513 (KRAS)
09183 Protein families: signaling and cellular processes
04031 GTP-binding proteins [BR:pon04031]
100462513 (KRAS)
Membrane trafficking [BR:pon04131]
Endocytosis
Macropinocytosis
Ras GTPases
100462513 (KRAS)
GTP-binding proteins [BR:pon04031]
Small (monomeric) G-proteins
Ras Family
Ras [OT]
100462513 (KRAS)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
10:complement(26469507..26515262)
|
AA seq |
189 aa
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDL
PSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGC
VKIKKCIIM |
NT seq |
570 nt +upstreamnt +downstreamnt
atgactgaatataaacttgtggtagttggagctggtggcgtaggcaagagtgccttgacg
atacagctaattcagaatcattttgtggacgaatatgatccaacaatagaggattcctac
aggaagcaagtagtaattgatggagaaacctgtctcttggatattctcgacacagcaggt
caagaggagtacagtgcaatgagggaccagtacatgaggactggggagggctttctttgt
gtatttgccataaataatactaaatcatttgaagatattcaccattatagagaacaaatt
aaaagagttaaggactctgaagatgtacctatggtcctagtaggaaataaatgtgatttg
ccttctagaacagtagacacaaaacaggctcaggacttagcaagaagttatggaattcct
tttattgaaacatcagcaaagacaagacagagagtggaggatgctttttatacattggtg
agagagatccgacaatacagattgaaaaaaatcagcaaagaagaaaagactcctggctgt
gtgaaaattaaaaaatgcattataatgtaa |